Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

IBRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

IBRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

ImmunityBio, Inc.(IBRX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

ImmunityBio, Inc.(IBRX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue0.614.7113.3141.0
-Cost of Revenue--0.88.7
Gross Profit0.614.7112.5132.2
-Operating Expenses362.9358.9368.6393.6
+Selling, General & Admin129.6168.8147.2157.5
+General And Administrative Expenses---—
+Selling And Marketing Expenses---—
+Research and Development232.4190.1207.9231.5
+Other Operating Expenses0.9-13.54.5
Operating Income-362.3-344.2-256.0-261.4
+Non Operating Income-307.5-198.7-201.4-696.7
+Interest Income, Net-85.9-129.3-105.8-103.6
+Interest Income0.92.46.78.5
-Interest Expense86.7131.7112.5112.1
+Other Non-Op Income-221.6-69.5-95.6-593.1
Pretax Income-583.9-413.6-351.6-854.5
-Income Tax Expense-0.0--0.10.1
Income from Cont Ops-583.9-413.6-351.5-854.6
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-583.9-413.6-351.5-854.6
-Minority Interests-0.7-0.1-0.1-0.1
Net Income, GAAP-583.2-413.6-351.4-854.5
-Prfrrd Div & Other----
Net Income Avail To Common-583.2-413.6-351.4-854.5
Weighted Average Shs Out508,636,000697,312,000919,863,0003,851,370,000
EPS-1.2-0.6-0.4-0.9
Weighted Average Shs Out Dil508,636,000700,443,000919,863,0003,851,370,000
EPS Diluted-1.2-0.6-0.4-0.9

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue0.614.7113.3141.0
-Cost of Revenue--0.88.7
Gross Profit0.614.7112.5132.2
-Operating Expenses362.9358.9368.6393.6
+Selling, General & Admin129.6168.8147.2157.5
+General And Administrative Expenses---—
+Selling And Marketing Expenses---—
+Research and Development232.4190.1207.9231.5
+Other Operating Expenses0.9-13.54.5
Operating Income-362.3-344.2-256.0-261.4
+Non Operating Income-307.5-198.7-201.4-696.7
+Interest Income, Net-85.9-129.3-105.8-103.6
+Interest Income0.92.46.78.5
-Interest Expense86.7131.7112.5112.1
+Other Non-Op Income-221.6-69.5-95.6-593.1
Pretax Income-583.9-413.6-351.6-854.5
-Income Tax Expense-0.0--0.10.1
Income from Cont Ops-583.9-413.6-351.5-854.6
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-583.9-413.6-351.5-854.6
-Minority Interests-0.7-0.1-0.1-0.1
Net Income, GAAP-583.2-413.6-351.4-854.5
-Prfrrd Div & Other----
Net Income Avail To Common-583.2-413.6-351.4-854.5
Weighted Average Shs Out508,636,000697,312,000919,863,0003,851,370,000
EPS-1.2-0.6-0.4-0.9
Weighted Average Shs Out Dil508,636,000700,443,000919,863,0003,851,370,000
EPS Diluted-1.2-0.6-0.4-0.9